GE HealthCare Technologies (NASDAQ:GEHC) Given New $110.00 Price Target at Citigroup

GE HealthCare Technologies (NASDAQ:GEHC) had its price target lifted by equities researchers at Citigroup from $103.00 to $110.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s target price indicates a potential upside of 17.67% from the company’s previous close.

Several other brokerages have also recently issued reports on GEHC. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $97.31.

GE HealthCare Technologies Price Performance

Shares of GEHC traded up $7.58 during trading hours on Thursday, reaching $93.48. 7,831,939 shares of the stock traded hands, compared to its average volume of 2,822,535. The company has a market cap of $42.71 billion, a P/E ratio of 25.68, a price-to-earnings-growth ratio of 2.93 and a beta of 1.15. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The company’s 50-day moving average price is $83.58 and its two-hundred day moving average price is $85.39. GE HealthCare Technologies has a 52-week low of $74.51 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. On average, analysts anticipate that GE HealthCare Technologies will post 4.3 earnings per share for the current year.

Institutional Trading of GE HealthCare Technologies

A number of hedge funds and other institutional investors have recently bought and sold shares of GEHC. LGT Financial Advisors LLC boosted its holdings in shares of GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares during the period. CoreFirst Bank & Trust bought a new stake in GE HealthCare Technologies during the 4th quarter valued at $25,000. Capital Performance Advisors LLP purchased a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth $26,000. Ashton Thomas Securities LLC bought a new position in shares of GE HealthCare Technologies during the 3rd quarter worth $26,000. Finally, Runnymede Capital Advisors Inc. purchased a new position in shares of GE HealthCare Technologies during the fourth quarter valued at $28,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.